亚虹医药-U股价波动下行，2025年业绩预亏，机构维持买入评级

Group 1 - The stock price of Yahuang Pharmaceutical-U has shown a downward trend over the past week, with a cumulative decline of 2.67% and a fluctuation of 2.99% [1] - On February 12, the closing price was 12.05 yuan, reflecting a daily decrease of 0.50% [1] - The total trading volume over the past week was approximately 398 million yuan, with an active turnover rate of 1.01% on February 12 [1] Group 2 - The company announced a projected net loss for 2025, with a potential year-on-year increase in losses of 18.00% or a decrease of 1.67% [2] - Expected operating revenue for 2025 is projected to grow by 20.30% to 4.436 billion yuan [2] - Research and development expenses are expected to decrease, with significant progress reported in clinical trials for bladder cancer and ulcerative colitis treatments [2] Group 3 - All institutions have given buy or hold ratings based on data from November and September 2025, indicating a 100% consensus [3] - There have been no significant changes in public sentiment or updates on institutional research and target price information [3]